HLA-DPβ residue 69 plays a crucial role in allorecognition

Tissue Antigens

Volumn 52, Issue 1, 1998, Pages 27-36

  Diaz G ^a   Catalfamo M ^b   Coiras, M T ^a   Alvarez A M ^c   Jaraquemada, D ^b   Nombela, C ^a   Sanchez Perez M ^a,c   Arroyo, J ^a,c  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Allorecognition; Epitopes; HLA DP antigens; Polymorphism; Site directed mutagenesis

Indexed keywords

HLA DP ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; COMPLEMENTARY DNA; EPITOPE; HLA DPB1; HLA-DPB1;

ALLELE; ALLOIMMUNITY; ARTICLE; B LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MOLECULAR RECOGNITION; PRIORITY JOURNAL; ANTIGEN PRESENTATION; CELL LINE; GENETICS; IMMUNOLOGY; LYMPHOCYTE FUNCTION; SITE DIRECTED MUTAGENESIS; T LYMPHOCYTE;

ALLELES; ANTIGEN PRESENTATION; B-LYMPHOCYTES; CELL LINE; DNA, COMPLEMENTARY; HLA-DP ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; LYMPHOCYTE COOPERATION; MUTAGENESIS, SITE-DIRECTED; T-LYMPHOCYTES;

EID: 0031594840     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1998.tb03020.x     Document Type: Article

References (53)

1. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature 1988: 334: 395-402.
2. Krensky AM, Weiss A, Crabtree G, Davis MM, Parham P. T-lymphocyte-antigen interactions in transplant rejection. N Engl J Med 1990: 322: 510-7.
3. Eckels DD. Alloreactivity: allogeneic presentation of endogenous peptide or direct recognition of MHC polymorphism? A review. Tissue Antigens 1990: 35: 49-55.
4. Newton-Nash DK. The molecular basis of allorecognition. Assessment of the involvement of peptide. Hum Immunol 1994: 41: 105-11.
5. Braun MY, McCormack A, Webb G, Batchelor JR. Mediation of acute but not chronic rejection of MHC-incompatible rat kidney grafts by alloreactive CD4 T cells activated by the direct pathway of sensitization. Transplantation 1993: 55: 177-82.
6. Sayegh MH, Carpenter CB. Role of indirect allorecognition in allograft rejection. Int Rev Immunol 1996: 13: 221-9.
7. Pawelec G, Adibzadeh M, Bornhak S et al., The role of endogenous peptides in the direct pathway of alloreactivity to human MHC class II molecules expressed on CHO cells. Immunol Rev 1996: 154: 155-73.
8. Colovai AI, Liu Z, Harris PE, Cortesini R, Suciu-Foca N. Allopeptide-specific T-cell reactivity altered by peptide analogs. J Immunol 1997: 158: 48-54.
9. Colovai AI, Renna-Molajoni E, Cocciolo PL et al. Suppression of allorecognition by use of synthetic peptides. Transplant Proc 1996: 28: 3029-31.
10. Stern LJ, Brown JH, Jardetzky TS et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994: 368: 215-21.
11. Ghosh P, Amaya M, Mellins E, Wiley DC. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 1995: 378: 457-62.
12. Garcia KC, Degano M, Stanfield RL et al. An alphabeta T-cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 1996: 274: 209-19.
13. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2 [comment]. Nature 1996: 384: 134-41.
14. Fu XT, Drover S, Marshall WH, Karr RW. HLA-DR residues accessible under the peptide-binding groove contribute to polymorphic antibody epitopes. Hum Immunol 1995: 43: 243-50.
15. Fu XT, Bono CP, Woulfe SL et al. Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide. J Exp Med 1995: 181: 915-26.
16. Signorelli KL, Watts LM, Lambert LE. The importance of DR4Dw4 beta chain residues 70, 71, and 86 in peptide binding and T-cell recognition. Cell Immunol 1995: 162: 217-24.
17. Zeliszewski D, Golvano JJ, Gaudebout P et al. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320. J Immunol 1993: 151: 6237-47.
18. Rosen-Bronson S, Yu WY, Karr RW. Polymorphic HLA-DR7 beta 1 chain residues that are involved in T-cell allorecognition. J Immunol 1991: 146: 4264-70.
19. Coppin HL, Carmichael P, Lombardi G et al. Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition. Eur J Immunol 1993: 23: 343-9.
20. Nishimura M, Mitsunaga S, Akaza T, Mitomi Y, Tadokoro K, Juji T. Alloreactive feature of HLA-DP-specific cytotoxic T-cell clone. Cell Immunol 1994: 153: 262-70.
21. de Koster HS, Kenter MJ, D'Amaro J et al. Positive correlation between oligonucleotide typing and T-cell recognition of HLA-DP molecules. Immunogenetics 1991: 34: 12-22.
22. Urlacher A, Dormoy A, Tongio MM. DP epitope mapping by using T-cell clones. Hum Immunol 1992: 35: 100-8.
23. Arroyo J, Alvarez AM, Nombela C, Sanchez-Perez M. The role of HLA-DP beta residue 69 in the definition of antibody-binding epitopes. Hum Immunol 1995: 43: 219-26.
24. Yu WY, Watts R, Karr RW. Identification of amino adds in HLA-DPw4b beta and -DR5 beta 1 chains that are involved in antibody binding epitopes using site-directed mutagenesis and DNA-mediated gene transfer. Hum Immunol 1990: 27: 122-35.
25. Sanchez-Perez M, Diez-Orejas R, Petersen JW, De MR, Shaw S. Differences in specificity of "DPw2-specific" cytotoxic T-cell clones revealed with HLA-mutant lines: evidence that non-DP HLA genes influence recognition by some clones. Eur J Immunol 1990: 20: 673-81.
26. Kavathas P, DeMars R, Bach FH. Hemizygous HLA mutants of lymphoblastoid cells: a new cell type for histocompatibility testing. Hum Immunol 1980: 1: 317-24.
27. Tonnelle C, DeMars R, Long EO. DO beta: a new beta chain gene in HLA-D with a distinct regulation of expression. EMBO J 1985: 4: 2839-47.
28. DeMars R, Chang CC, Rudersdorf RA. Dissection of the D-region of the human major histocompatibility complex by means of induced mutations in a lymphoblastoid cell line. Hum Immunol 1983: 8: 123-39.
29. Arroyo J, Diez-Orejas R, Alvarez AM, Shaw S, Sanchez-Perez M. Molecular analysis of an HLA-DP mutant cell line selected for its resistance to killing by HLA-DPw2-specific T-cell clones. Immunogenetics 1994: 39: 40-7.
30. Biddison WE, Rao PE, Talle MA, Goldstein G, Shaw S. Possible involvement of the OKT4 molecule in T-cell recognition of class II HLA antigens. Evidence from studies of cytotoxic T lymphocytes specific for SB antigens. J Exp Med 1982: 156: 1065-76.
31. Royston I, Omary MB, Trowbridge IS. Monoclonal antibodies to a human T-cell antigen and Ia-like antigen in the characterization of lymphoid leukemia. Transplant Proc 1981: 13: 761-6.
32. Watson AJ, DeMars R, Trowbridge IS, Bach FH. Detection of a novel human class II HLA antigen. Nature 1983: 304: 358-61.
33. Nadler LM, Stashenko P, Hardy R, Pesando JM, Yunis EJ, Schlossman SF. Monoclonal antibodies defining serologically distinct HLA-D/DR related la-like antigens in man. Hum Immunol 1981: 2: 77-90.
34. Heyes J, Austin P, Bodmer J et al. Monoclonal antibodies to HLA-DP-transfected mouse L cells. Proc Natl Acad Sci U S A 1986: 83: 3417-21.
35. Drover S, Codner D, Gamberg J, Hutchings L, Marshall WH. A site-specific anti-HLA-DP monoclonal antibody recognizes molecules bearing "DE" at positions 55 and 56 on the beta chain. Tissue Antigens 1991: 38: 37-40.
36. Inoko H, Bodmer JG, Heyes JM, Drover S, Trowsdale J, Marshall WH. Joint report on the transfectant-monoclonal antibody component. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991. Oxford: Oxford University Press, 1992: 919-30.
37. Marshall WH, Drover S, Mervart H, Younghusband HB, Liu H. Production of a series of monoclonal antibodies to polymorphisms of HLA-DP. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991. Oxford: Oxford University Press, 1992: 415-6.
38. Brown JH, Jardetzky TS, Gorga JC et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993: 364: 33-9.
39. Chicz RM, Graziano DF, Trucco M, Strominger JL, Gorga JC. HLA-DP2: self peptide sequences and binding properties. J Immunol 1997: 159: 4935-42.
40. Dessen A, Lawrence CM, Cupo S, Zaller DM, Wiley DC. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity 1997: 7: 473-81.
41. Klohe E, Fu XT, Ballas M, Karr RW. HLA-DR beta chain residues that are predicted to be located in the floor of the peptide-binding groove contribute to antibody-binding epitopes. Hum Immunol 1993: 37: 51-8.
42. Olson KR, De MM, Di TA, Karr RW. Mutations in the third, but not the first or second, hypervariable regions of DR(beta 1*0101) eliminate DR1-restricted recognition of a pertussis toxin peptide. J Immunol 1992: 148: 2703-8.
43. Claverie JM, Prochnicka-Chalufour A, Bougueleret L. Implications of a Fab-like structure for the T-cell receptor. Immunol Today 1989: 10: 10-4.
44. Hong SC, Sant'Angelo DB, Dittel BN et al. The orientation of a T-cell receptor to its MHC class II:peptide ligands. J Immunol 1997: 159: 4395-402.
45. Smith PA, Brunmark A, Jackson MR, Potter TA. Peptide-independent recognition by alloreactive cytotoxic T lymphocytes (CTL). J Exp Med 1997: 185: 1023-33.
46. Weber DA, Terrell NK, Zhang Y et al. Requirement for peptide in alloreactive CD4+ T-cell recognition of class II MHC molecules. J Immunol 1995: 154: 5153-64.
47. Potolicchio I, Brookes PA, Madrigal A, Lechler RI, Sorrentino R. HLA-DPB1 mismatch at position 69 is associated with high helper T lymphocyte precursor frequencies in unrelated bone marrow transplant pairs. Transplantation 1996: 62: 1347-52.
48. Nicholson I, Varney M, Kanaan C et al. Alloresponses to HLA-DP detected in the primary MLR: correlation with a single amino acid difference. Hum Immunol 1997: 55: 163-9.
49. Karr RW, Yu W, Watts R, Evans KS, Celis E. The role of polymorphic HLA-DR beta chain residues in presentation of viral antigens to T cells. J Exp Med 1990: 172: 273-83.
50. Bugawan TL, Angelini G, Larrick J, Auricchio S, Ferrara GB, Erlich HA. A combination of a particular HLA-DP beta allele and an HLA-DQ heterodimer confers susceptibility to coeliac disease. Nature 1989: 339: 470-3.
51. Begovich AB, Bugawan TL, Nepom BS, Klitz W, Nepom GT, Erlich HA. A specific HLA-DP beta allele is associated with pauciarticular juvenile rheumatoid arthritis but not adult rheumatoid arthritis. Pror Natl Acad Sci U S A 1989: 86: 9489-93.
52. Richeldi L, Sorrentino R, Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 1993: 262: 242-4.
53. Potolicchio I, Mosconi G, Forni A, Nemery B, Seghizzi P, Sorrentino R. Susceptibility to hard metal lung disease is strongly associated with the presence of glutamate 69 in HLA-DP beta chain. Eur J Immunol 1997: 27: 2741-3.